Over 300 attendees representing global pharmaceutical organisations, leading biotech and internationally renowned academic institutions.

Over 30 case studies, presentations, panel debates & roundtable discussions focused on the key issues in protein & antibody engineering, characterisation & developability updates and vaccine development.

Supported digitally on our fully featured online event platform, with headline talks live-streaming from the auditorium, selected presentations available to watch on-demand, and extensive networking features.